Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study
Chen Chen(First Affiliated Hospital of Xi'an Jiaotong University), Zhaohui Tang(Shanxi Agricultural University), Yinghe Qiu(Second Military Medical University), Yu He(Southern University of Science and Technology), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), Wenlong Zhai(Zhengzhou University), Zhangjun Cheng(Zhongda Hospital Southeast University), Xianhan Mao(Hunan Provincial People's Hospital), Jingdong Li(Sun Yat-sen University), Jingbo Su(Xijing Hospital), Hong Wu(Sichuan University)
Cited by 18
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
|Gut|2020|578
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial
|The Lancet. Gastroenterology & hepatology|2021|268